Kate Haviland, the Chief Executive Officer of Blueprint Medicines Corp (NASDAQ:BPMC), a biotechnology company with a market capitalization of $7.3 billion, has sold a portion of her holdings in the ...
BOSTON—Thomas Corey E., CEO of Rapid7, Inc. (NASDAQ:RPD), recently executed a significant stock transaction, according to a ...
Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics has now set its financial goalposts, aiming to raise $114.4m from the initial public ...
Atlanta-based T Stamp Inc. (NASDAQ:IDAI), a prepackaged software services company with a market capitalization of $8.46 ...
Hyzon Motors Inc. (NASDAQ:HYZN), a manufacturer specializing in electrical industrial apparatus, is set to be delisted from the Nasdaq Stock Market, as announced on Thursday. The company received a ...
Ribbon Acquisition Corp , a special purpose acquisition company (SPAC), has successfully completed its initial public offering (IPO), raising $52.2 million in total proceeds. The company, which trades ...
Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced that its Board of Directors has declared a quarterly cash dividend on Costco common stock of $1.16 per share.
US stocks closed up, with the S&P 500 notching a record for the 2nd day. Trump called for lower rates and oil prices in remarks to world leaders.
In a notable surge, Distoken Acquisition Corp. (DIST) stock has reached a 52-week high, touching $11.4 as investors rally ...
Genmab A/S (NASDAQ:GMAB), a Denmark-based biotechnology company with a market capitalization of $13.4 billion, announced today that it has granted restricted stock units and warrants to its employees.
Issuers listed on the Nasdaq Stock Market and the New York Stock Exchange (NYSE) often conduct reverse stock splits to maintain compliance with each exchange’s US$1.00 minimum share price requirement.
Study participants in the PK run-in study are randomized 2:1 to receive either nomlabofusp or placebo daily for seven days. Following assessment of safety and PK data of each successive cohort, ...